159 related articles for article (PubMed ID: 25432437)
1. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).
Kato M; Manabe A; Saito AM; Koh K; Inukai T; Ogawa C; Goto H; Tsuchida M; Ohara A
Int J Hematol; 2015 Jan; 101(1):52-7. PubMed ID: 25432437
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
4. Survival outcome after the first central nervous system relapse in children with acute lymphoblastic leukemia: a retrospective analysis of 79 patients in a joint program involving the experience of three Japanese study groups.
Tsurusawa M; Yumura-Yagi K; Ohara A; Hara J; Katano N; Tsuchida M;
Int J Hematol; 2007 Jan; 85(1):36-40. PubMed ID: 17261500
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
Tsuchida M; Ohara A; Manabe A; Kumagai M; Shimada H; Kikuchi A; Mori T; Saito M; Akiyama M; Fukushima T; Koike K; Shiobara M; Ogawa C; Kanazawa T; Noguchi Y; Oota S; Okimoto Y; Yabe H; Kajiwara M; Tomizawa D; Ko K; Sugita K; Kaneko T; Maeda M; Inukai T; Goto H; Takahashi H; Isoyama K; Hayashi Y; Hosoya R; Hanada R;
Leukemia; 2010 Feb; 24(2):383-96. PubMed ID: 20033052
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.
Kato M; Manabe A; Koh K; Inukai T; Kiyokawa N; Fukushima T; Goto H; Hasegawa D; Ogawa C; Koike K; Ota S; Noguchi Y; Kikuchi A; Tsuchida M; Ohara A
Int J Hematol; 2014 Aug; 100(2):180-7. PubMed ID: 24938380
[TBL] [Abstract][Full Text] [Related]
8. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
9. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
11. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
[TBL] [Abstract][Full Text] [Related]
13. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
14. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
15. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
16. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
17. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and outcome of relapsed acute lymphoblastic leukemia: a Hong Kong Pediatric Hematology and Oncology Study Group report.
Leung AW; Vincent L; Chiang AK; Lee AC; Cheng FW; Cheuk DK; Luk CW; Ling SC; Li CK
Pediatr Blood Cancer; 2012 Sep; 59(3):454-60. PubMed ID: 22610685
[TBL] [Abstract][Full Text] [Related]
19. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Wofford MM; Smith SD; Shuster JJ; Johnson W; Buchanan GR; Wharam MD; Ritchey AK; Rosen D; Haggard ME; Golembe BL
J Clin Oncol; 1992 Apr; 10(4):624-30. PubMed ID: 1548525
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.
Kato M; Ishida H; Koh K; Inagaki J; Kato K; Goto H; Kaneko T; Cho Y; Hashii Y; Kurosawa H; Takita J; Hamamoto K; Inoue M; Sawada A; Suzuki R; Kato K
Pediatr Blood Cancer; 2015 Oct; 62(10):1844-50. PubMed ID: 26053959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
